BFBIO begins commercial production at Line II

MG News | February 28, 2025 at 09:34 PM GMT+05:00

0:00

February 28, 2025 (MLN): BF Biosciences Limited (PSX: BFBIO) has successfully commissioned its Line II expansion project, with commercial production now underway.

Following the period-end, the company has introduced four new pharmaceutical products: Heprin (Heparin Sodium), Peg-Filgen (Pegylated Filgrastim), Ferium (Ferric Carboxymaltose), and Serenety (Ondansetron).

The company reported strong financial performance, with earnings per share (EPS) rising to Rs2.66 from Rs2.42.

Revenue surged 46.4% to Rs2.7 billion, driven by higher sales and market expansion.

Gross profit increased 67.5% to Rs1bn, despite a 33.4% rise in the cost of goods sold.

Administrative and selling expenses saw significant jumps due to expansion efforts.

Other income grew 66% to Rs52m, supporting earnings, while finance costs rose 18% to Rs92.6m.

Profit before tax climbed 29.4% to Rs322.4m, though higher tax expenses slowed net profit growth.

Copyright Mettis Link News

Related News

SCRA records Rs.3.74 bn net sale of securities

JDW Sugar Mills commences commercial operations at new Ethanol Plant

Bank Makramah finalizes sale of Cullinan Tower

Name	Price/Vol	%Chg/NChg
KSE100	141,034.99 304.55M	1.18% 1644.56
ALLSHR	87,318.24 607.11M	1.23% 1057.27
KSE30	43,334.54 168.35M	1.68% 715.94
KMI30	201,116.98 176.63M	2.14% 4209.12
KMIALLSHR	58,357.22 362.26M	1.89% 1080.35
BKTi	38,265.16 18.85M	1.18% 444.89
OGTi	29,938.42 82.25M	6.11% 1723.79

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	114,265.00	117,125.00 113,440.00	-3170.00 -2.70%
BRENT CRUDE	69.52	72.00 69.40	-2.18 -3.04%
RICHARDS BAY COAL MONTHLY	96.50	0.00 0.00	2.20 2.33%
ROTTERDAM COAL MONTHLY	104.50	104.50 104.50	-0.30 -0.29%
USD RBD PALM OLEIN	998.50	998.50 998.50	0.00 0.00%
CRUDE OIL - WTI	67.26	69.58 67.05	-2.00 -2.89%
SUGAR #11 WORLD	16.20	16.42 16.12	-0.15 -0.92%